BioCare Group, Uzbekistan Discuss Insulin Production Localization
Algerian company BioCare Group has engaged with Uzbekistan's medical agency to discuss pharmaceutical cooperation, specifically exploring the localization of insulin production.
Representatives from Algeria and Uzbekistan convened on November 5, 2026, in Tashkent to explore avenues for cooperation within the pharmaceutical industry. The discussions featured Abdulla Azizov, Director of Uzbekistan's Agency for the Development of the Medical and Pharmaceutical Industry, and Amir Habbes, General Director of the Algerian company BioCare Group. The meeting focused on enhancing collaboration in pharmaceutical production.
A significant portion of the discussions centered on the prospects for insulin production, including its localization on Uzbekistan's territory. Participants also addressed strategies for the effective utilization of existing manufacturing capacities, attracting foreign investments into the sector, and the adoption of new technologies to advance pharmaceutical development in both nations.
The parties exchanged perspectives on identifying mutually beneficial directions for interaction and the potential implementation of joint projects. While specific agreements regarding the launch of production or project timelines were not detailed during this meeting, the talks represent a constructive step in exploring international pharmaceutical cooperation.
